HomeTELO • NASDAQ
add
Telomir Pharmaceuticals Inc
Nakaraang pagsara
$1.66
Sakop ng araw
$1.61 - $1.70
Sakop ng taon
$1.12 - $7.08
Market cap
51.98M USD
Average na Volume
3.10M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 5.07M | 243.84% |
Net na kita | -5.07M | -249.89% |
Net profit margin | — | — |
Kita sa bawat share | -0.17 | — |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 754.32K | -59.96% |
Kabuuang asset | 829.61K | -60.53% |
Kabuuang sagutin | 348.39K | -34.78% |
Kabuuang equity | 481.22K | — |
Natitirang share | 32.28M | — |
Presyo para makapag-book | 83.00 | — |
Return on assets | -1,919.26% | — |
Return on capital | -5,000.11% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -5.07M | -249.89% |
Cash mula sa mga operasyon | -696.44K | 54.27% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 1.05M | 691.14% |
Net change in cash | 351.32K | 125.27% |
Malayang cash flow | -3.46M | -247.65% |
Tungkol
Itinatag
2021
Headquarters
Website
Mga Empleyado
5
